122 related articles for article (PubMed ID: 38886396)
1. C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer.
Razavipour SF; Yoon H; Jang K; Kim M; Nawara HM; Bagheri A; Huang WC; Shin M; Zhao D; Zhou Z; Van Boven D; Briegel K; Morey L; Ince TA; Johnson M; Slingerland JM
Nat Commun; 2024 Jun; 15(1):5152. PubMed ID: 38886396
[TBL] [Abstract][Full Text] [Related]
2. p27 transcriptionally coregulates cJun to drive programs of tumor progression.
Yoon H; Kim M; Jang K; Shin M; Besser A; Xiao X; Zhao D; Wander SA; Briegel K; Morey L; Minn A; Slingerland JM
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7005-7014. PubMed ID: 30877256
[TBL] [Abstract][Full Text] [Related]
3. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
[TBL] [Abstract][Full Text] [Related]
5. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
6. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
Sizemore GM; Balakrishnan S; Hammer AM; Thies KA; Trimboli AJ; Wallace JA; Sizemore ST; Kladney RD; Woelke SA; Yu L; Fernandez SA; Chakravarti A; Leone G; Ostrowski MC
Oncogene; 2017 Apr; 36(16):2297-2308. PubMed ID: 27797378
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
8. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690
[TBL] [Abstract][Full Text] [Related]
10. s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells.
Tian L; Truong MJ; Lagadec C; Adriaenssens E; Bouchaert E; Bauderlique-Le Roy H; Figeac M; Le Bourhis X; Bourette RP
Stem Cell Reports; 2019 Jul; 13(1):10-20. PubMed ID: 31204299
[TBL] [Abstract][Full Text] [Related]
11. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
12. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM
Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936
[TBL] [Abstract][Full Text] [Related]
13. p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling.
Memmi EM; Sanarico AG; Giacobbe A; Peschiaroli A; Frezza V; Cicalese A; Pisati F; Tosoni D; Zhou H; Tonon G; Antonov A; Melino G; Pelicci PG; Bernassola F
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3499-504. PubMed ID: 25739959
[TBL] [Abstract][Full Text] [Related]
14. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
16. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.
Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK
Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474
[TBL] [Abstract][Full Text] [Related]
17. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
18. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
[TBL] [Abstract][Full Text] [Related]
20. eIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells.
Avdulov S; Herrera J; Smith K; Peterson M; Gomez-Garcia JR; Beadnell TC; Schwertfeger KL; Benyumov AO; Manivel JC; Li S; Bielinsky AK; Yee D; Bitterman PB; Polunovsky VA
Cancer Res; 2015 Feb; 75(4):687-97. PubMed ID: 25524901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]